VALABREGA, Giorgio
VALABREGA, Giorgio
ONCOLOGIA
Abstract 3102: Identification of actionable cancer genes and treatment options for metastatic ovarian carcinomas using patient-derived xenografts and PDX-derived tumor cells
2018-01-01 Olivero, Martina; Erriquez, Jessica; Arigoni, Maddalena; Capellero, Sonia; D'Ambrosio, Concetta; Mittica, Gloria; Borella, Fulvio; Katsaros, Dionyssios; Privitera, Silvana; Berrino, Enrico; Venesio, Tiziana; Valabrega, Giorgio; Calogero, Raffaele; Renzo, Maria Flavia Di
Active immunotherapy in HER2 overexpressing breast cancer: current status and future perspectives.
2013-01-01 Milani A;Sangiolo D;Montemurro F;Aglietta M;Valabrega G
Adoptive immunotherapy against ovarian cancer
2016-01-01 Mittica, Gloria; Capellero, Sonia; Genta, Sofia; Cagnazzo, Celeste; Aglietta, Massimo; Sangiolo, Dario; Valabrega, Giorgio
Androgen receptor status predicts development of brain metastases in ovarian cancers
2017-01-01 Mittica, Gloria; Senetta, Rebecca; Scotto, Giulia; Aglietta, Massimo; Maggiorotto, Furio; Ghisoni, Eleonora; Genta, Sofia; Boldorini, Renzo; Manini, Claudia; Morra, Isabella; Buosi, Roberta; Sapino, Anna; Cassoni, Paola; Valabrega, Giorgio
Are cyclin-dependent kinases 4/6 inhibitors ready for prime time in estrogen-receptor positive metastatic breast cancer?
2017-01-01 Genta, Sofia; Mittica, Gloria; Giannone, Gaia; Ghisoni, Eleonora; Valabrega, Giorgio
ASO Visual Abstract: Clinical and Histopathologic Predictors Signaling Recurrence of Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Multicenter Retrospective Cohort Study of Tertiary Centers
2022-01-01 Borella, Fulvio; Cosma, Stefano; Ferraioli, Domenico; Ray-Coquard, Isabelle; Chopin, Nicolas; Meeus, Pierre; Cockenpot, Vincent; Valabrega, Giorgio; Scotto, Giulia; Turinetto, Margherita; Biglia, Nicoletta; Fuso, Luca; Mariani, Luca; Franchi, Dorella; Urbinati, Ailyn Mariela Vidal; Pino, Ida; Bertschy, Gianluca; Preti, Mario; Benedetto, Chiara; Castellano, Isabella; Cassoni, Paola; Bertero, Luca
Assays of conventional chemotherapeutics and targeted drugs for ovarian cancer using patient derived models
2019-01-01 Concetta D’Ambrosio, Jessica Erriquez, Maddalena Arigoni, Sonia Capellero, Gloria Mittica, Eleonora Ghisoni, Fulvio Borella, Dionyssios Katsaros, Silvana Privitera, Marisa Ribotta, Elena Maldi, Giovanna Di Nardo, Enrico Berrino, Tiziana Venesio, Riccardo Ponzone, Marco Vaira, Douglas Hall, Mercedes Jimenez-Linan, Anna L. Paterson, Giorgio Valabrega, Raffaele A. Calogero, James D. Brenton, Maria Flavia Di Renzo and Martina Olivero
Author Correction: Modeling ErbB2-p130Cas interaction to design new potential anticancer agents (Scientific Reports, (2019), 9, 1, (3089), 10.1038/s41598-019-39510-w)
2019-01-01 Costamagna A.; Rossi Sebastiano M.; Natalini D.; Simoni M.; Valabrega G.; Defilippi P.; Visentin S.; Ermondi G.; Turco E.; Caron G.; Cabodi S.
Biomarkers of central nervous system involvement from epithelial ovarian cancer
2021-01-01 Scotto G.; Borella F.; Turinetto M.; Tuninetti V.; Valsecchi A.A.; Giannone G.; Cosma S.; Benedetto C.; Valabrega G.
Brain Metastases from Ovarian Cancer: Current Evidence in Diagnosis, Treatment, and Prognosis
2020-01-01 Borella, Fulvio; Bertero, Luca; Morrone, Antonio; Gambella, Alessandro; Bovetti, Marialuisa; Cosma, Stefano; Carosso, Andrea; Katsaros, Dionyssios; Gemmiti, Silvia; Preti, Mario; Valabrega, Giorgio; Scotto, Giulia; Cassoni, Paola; Benedetto, Chiara
Buparlisib , an oral pan-PI3K inhibitor for the treatment of breast cancer
2015-01-01 Geuna, Elena; Milani, Andrea; Martinello, Rossella; Aversa, Caterina; Valabrega, Giorgio; Scaltriti, Maurizio; Montemurro, Filippo
Cancer Cells Haploinsufficient for ATM Are Sensitized to PARP Inhibitors by MET Inhibition
2022-01-01 D'Ambrosio, Concetta; Erriquez, Jessica; Capellero, Sonia; Cignetto, Simona; Alvaro, Maria; Ciamporcero, Eric; Di Renzo, Maria Flavia; Perera, Timothy; Valabrega, Giorgio; Olivero, Martina
CAR-Based Strategies beyond T Lymphocytes: Integrative Opportunities for Cancer Adoptive Immunotherapy
2019-01-01 Rotolo, Ramona; Leuci, Valeria; Donini, Chiara; Cykowska, Anna; Gammaitoni, Loretta; Medico, Giovanni; Valabrega, Giorgio; Aglietta, Massimo; Sangiolo, Dario
Characteristics and outcome of BRCA mutated epithelial ovarian cancer patients in Italy: A retrospective multicenter study (MITO 21)
2021-01-01 Artioli G.; Giannone G.; Valabrega G.; Maggiorotto F.; Genta S.; Pignata S.; Lorusso D.; Cormio G.; Scalone S.; Nicoletto M.O.; Greco F.; Rossi E.; Spagnoletti I.; De Giorgi U.; Orditura M.; Mosconi A.M.; Kardhashi A.; Bogliolo S.; Borgato L.
Checkpoint inhibitors in endometrial cancer: Preclinical rationale and clinical activity
2017-01-01 Mittica, Gloria; Ghisoni, Eleonora; Giannone, Gaia; Aglietta, Massimo; Genta, Sofia; Valabrega, Giorgio
Clinical and Histopathological Predictors of Recurrence in Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Multicenter Retrospective Cohort Study of Tertiary Centers
2022-01-01 Borella, Fulvio; Cosma, Stefano; Ferraioli, Domenico; Ray-Coquard, Isabelle; Chopin, Nicolas; Meeus, Pierre; Cockenpot, Vincent; Valabrega, Giorgio; Scotto, Giulia; Turinetto, Margherita; Biglia, Nicoletta; Fuso, Luca; Mariani, Luca; Franchi, Dorella; Vidal Urbinati, Ailyn Mariela; Pino, Ida; Bertschy, Gianluca; Preti, Mario; Benedetto, Chiara; Castellano, Isabella; Cassoni, Paola; Bertero, Luca
Clinical characteristics and molecular aspects of low-grade serous ovarian and peritoneal cancer: a multicenter, observational, retrospective analysis of MITO Group (MITO 22)
2022-01-01 Musacchio, Lucia; Califano, Daniela; Bartoletti, Michele; Arenare, Laura; Lorusso, Domenica; Losito, Nunzia Simona; Cormio, Gennaro; Greggi, Stefano; Raspagliesi, Francesco; Valabrega, Giorgio; Salutari, Vanda; Pisano, Carmela; Spina, Anna; Russo, Daniela; Del Sesto, Michele; Canzonieri, Vincenzo; Ferraù, Francesco; Zannoni, Gian Franco; Loizzi, Vera; Ghizzoni, Viola; Casanova, Claudia; Tuninetti, Valentina; Ducceschi, Monika; Del Vecchio, Vittoria; Scalone, Simona; Priolo, Domenico; Perrone, Francesco; Scambia, Giovanni; Pignata, Sandro
Clinical implications of DNA repair defects in high-grade serous ovarian carcinomas
2020-01-01 Milanesio M.C.; Giordano S.; Valabrega G.
Concurrent radiotherapy does not affect adjuvant CMF delivery but is associated with increased toxicity in women with early breast cancer
2006-01-01 MONTEMURRO F; GATTI M; REDANA S; JACOMUZZI ME; NANNI D; DURANDO A; POPOLO M; PONZONE R; ROSSI A; ALBIERI V; VALABREGA G; SISMONDI P; GABRIELE P; AGLIETTA M
Controversies in breast cancer: adjuvant and neoadjuvant therapy
2005-01-01 F. MONTEMURRO; S. REDANA; G. VALABREGA; M. AGLIETTA
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Abstract 3102: Identification of actionable cancer genes and treatment options for metastatic ovarian carcinomas using patient-derived xenografts and PDX-derived tumor cells | 2018 | Olivero, Martina; Erriquez, Jessica; Arigoni, Maddalena; Capellero, Sonia; D'Ambrosio, Concetta; Mittica, Gloria; Borella, Fulvio; Katsaros, Dionyssios; Privitera, Silvana; Berrino, Enrico; Venesio, Tiziana; Valabrega, Giorgio; Calogero, Raffaele; Renzo, Maria Flavia Di | |
| Active immunotherapy in HER2 overexpressing breast cancer: current status and future perspectives. | 2013 | Milani A;Sangiolo D;Montemurro F;Aglietta M;Valabrega G | |
| Adoptive immunotherapy against ovarian cancer | 2016 | Mittica, Gloria; Capellero, Sonia; Genta, Sofia; Cagnazzo, Celeste; Aglietta, Massimo; Sangiolo, Dario; Valabrega, Giorgio | |
| Androgen receptor status predicts development of brain metastases in ovarian cancers | 2017 | Mittica, Gloria; Senetta, Rebecca; Scotto, Giulia; Aglietta, Massimo; Maggiorotto, Furio; Ghisoni, Eleonora; Genta, Sofia; Boldorini, Renzo; Manini, Claudia; Morra, Isabella; Buosi, Roberta; Sapino, Anna; Cassoni, Paola; Valabrega, Giorgio | |
| Are cyclin-dependent kinases 4/6 inhibitors ready for prime time in estrogen-receptor positive metastatic breast cancer? | 2017 | Genta, Sofia; Mittica, Gloria; Giannone, Gaia; Ghisoni, Eleonora; Valabrega, Giorgio | |
| ASO Visual Abstract: Clinical and Histopathologic Predictors Signaling Recurrence of Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Multicenter Retrospective Cohort Study of Tertiary Centers | 2022 | Borella, Fulvio; Cosma, Stefano; Ferraioli, Domenico; Ray-Coquard, Isabelle; Chopin, Nicolas; Meeus, Pierre; Cockenpot, Vincent; Valabrega, Giorgio; Scotto, Giulia; Turinetto, Margherita; Biglia, Nicoletta; Fuso, Luca; Mariani, Luca; Franchi, Dorella; Urbinati, Ailyn Mariela Vidal; Pino, Ida; Bertschy, Gianluca; Preti, Mario; Benedetto, Chiara; Castellano, Isabella; Cassoni, Paola; Bertero, Luca | |
| Assays of conventional chemotherapeutics and targeted drugs for ovarian cancer using patient derived models | 2019 | Concetta D’Ambrosio, Jessica Erriquez, Maddalena Arigoni, Sonia Capellero, Gloria Mittica, Eleonora Ghisoni, Fulvio Borella, Dionyssios Katsaros, Silvana Privitera, Marisa Ribotta, Elena Maldi, Giovanna Di Nardo, Enrico Berrino, Tiziana Venesio, Riccardo Ponzone, Marco Vaira, Douglas Hall, Mercedes Jimenez-Linan, Anna L. Paterson, Giorgio Valabrega, Raffaele A. Calogero, James D. Brenton, Maria Flavia Di Renzo and Martina Olivero | |
| Author Correction: Modeling ErbB2-p130Cas interaction to design new potential anticancer agents (Scientific Reports, (2019), 9, 1, (3089), 10.1038/s41598-019-39510-w) | 2019 | Costamagna A.; Rossi Sebastiano M.; Natalini D.; Simoni M.; Valabrega G.; Defilippi P.; Visentin S.; Ermondi G.; Turco E.; Caron G.; Cabodi S. | |
| Biomarkers of central nervous system involvement from epithelial ovarian cancer | 2021 | Scotto G.; Borella F.; Turinetto M.; Tuninetti V.; Valsecchi A.A.; Giannone G.; Cosma S.; Benedetto C.; Valabrega G. | |
| Brain Metastases from Ovarian Cancer: Current Evidence in Diagnosis, Treatment, and Prognosis | 2020 | Borella, Fulvio; Bertero, Luca; Morrone, Antonio; Gambella, Alessandro; Bovetti, Marialuisa; Cosma, Stefano; Carosso, Andrea; Katsaros, Dionyssios; Gemmiti, Silvia; Preti, Mario; Valabrega, Giorgio; Scotto, Giulia; Cassoni, Paola; Benedetto, Chiara | |
| Buparlisib , an oral pan-PI3K inhibitor for the treatment of breast cancer | 2015 | Geuna, Elena; Milani, Andrea; Martinello, Rossella; Aversa, Caterina; Valabrega, Giorgio; Scaltriti, Maurizio; Montemurro, Filippo | |
| Cancer Cells Haploinsufficient for ATM Are Sensitized to PARP Inhibitors by MET Inhibition | 2022 | D'Ambrosio, Concetta; Erriquez, Jessica; Capellero, Sonia; Cignetto, Simona; Alvaro, Maria; Ciamporcero, Eric; Di Renzo, Maria Flavia; Perera, Timothy; Valabrega, Giorgio; Olivero, Martina | |
| CAR-Based Strategies beyond T Lymphocytes: Integrative Opportunities for Cancer Adoptive Immunotherapy | 2019 | Rotolo, Ramona; Leuci, Valeria; Donini, Chiara; Cykowska, Anna; Gammaitoni, Loretta; Medico, Giovanni; Valabrega, Giorgio; Aglietta, Massimo; Sangiolo, Dario | |
| Characteristics and outcome of BRCA mutated epithelial ovarian cancer patients in Italy: A retrospective multicenter study (MITO 21) | 2021 | Artioli G.; Giannone G.; Valabrega G.; Maggiorotto F.; Genta S.; Pignata S.; Lorusso D.; Cormio G.; Scalone S.; Nicoletto M.O.; Greco F.; Rossi E.; Spagnoletti I.; De Giorgi U.; Orditura M.; Mosconi A.M.; Kardhashi A.; Bogliolo S.; Borgato L. | |
| Checkpoint inhibitors in endometrial cancer: Preclinical rationale and clinical activity | 2017 | Mittica, Gloria; Ghisoni, Eleonora; Giannone, Gaia; Aglietta, Massimo; Genta, Sofia; Valabrega, Giorgio | |
| Clinical and Histopathological Predictors of Recurrence in Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Multicenter Retrospective Cohort Study of Tertiary Centers | 2022 | Borella, Fulvio; Cosma, Stefano; Ferraioli, Domenico; Ray-Coquard, Isabelle; Chopin, Nicolas; Meeus, Pierre; Cockenpot, Vincent; Valabrega, Giorgio; Scotto, Giulia; Turinetto, Margherita; Biglia, Nicoletta; Fuso, Luca; Mariani, Luca; Franchi, Dorella; Vidal Urbinati, Ailyn Mariela; Pino, Ida; Bertschy, Gianluca; Preti, Mario; Benedetto, Chiara; Castellano, Isabella; Cassoni, Paola; Bertero, Luca | |
| Clinical characteristics and molecular aspects of low-grade serous ovarian and peritoneal cancer: a multicenter, observational, retrospective analysis of MITO Group (MITO 22) | 2022 | Musacchio, Lucia; Califano, Daniela; Bartoletti, Michele; Arenare, Laura; Lorusso, Domenica; Losito, Nunzia Simona; Cormio, Gennaro; Greggi, Stefano; Raspagliesi, Francesco; Valabrega, Giorgio; Salutari, Vanda; Pisano, Carmela; Spina, Anna; Russo, Daniela; Del Sesto, Michele; Canzonieri, Vincenzo; Ferraù, Francesco; Zannoni, Gian Franco; Loizzi, Vera; Ghizzoni, Viola; Casanova, Claudia; Tuninetti, Valentina; Ducceschi, Monika; Del Vecchio, Vittoria; Scalone, Simona; Priolo, Domenico; Perrone, Francesco; Scambia, Giovanni; Pignata, Sandro | |
| Clinical implications of DNA repair defects in high-grade serous ovarian carcinomas | 2020 | Milanesio M.C.; Giordano S.; Valabrega G. | |
| Concurrent radiotherapy does not affect adjuvant CMF delivery but is associated with increased toxicity in women with early breast cancer | 2006 | MONTEMURRO F; GATTI M; REDANA S; JACOMUZZI ME; NANNI D; DURANDO A; POPOLO M; PONZONE R; ROSSI A; ALBIERI V; VALABREGA G; SISMONDI P; GABRIELE P; AGLIETTA M | |
| Controversies in breast cancer: adjuvant and neoadjuvant therapy | 2005 | F. MONTEMURRO; S. REDANA; G. VALABREGA; M. AGLIETTA |